Intelligence registry
Public-source dossierus-fdadq-aad73d56b618aba3a48bfa6b2207d78f607af180
Public source recordpersonProcurement exclusion

Manuel Sanguilly

Authority: Debarment and ExclusionsCoverage: usPage generated: 2026-09-10
Evidence class
Public source record
Coverage
us
Record category
Procurement exclusion
Page generated
2026-09-10
Linked public records

No verified ownership, offshore or transport links have been attached to this record yet.

Source and status notice
Verify the underlying publisher and original record before relying on this information. Always verify the live source record and identifiers before relying on this page.

Compliance Profile

"Public-record notice: Manuel Sanguilly appears in public source record data. The record is informational and should be checked against the original publisher before legal, financial or counterparty decisions are made."

Banking Impact

This public record does not establish a banking prohibition. Any onboarding or transaction decision should use the original source, a verified identity match and the institution's applicable legal framework.

Legal Status

This is an informational public record, not a sanctions, exclusion or enforcement conclusion unless the page expressly identifies an official issuing authority and record.

Public source metadata

Source: Debarment and Exclusions
Full Legal NameManuel Sanguilly
Countries / jurisdictionsus
Source datasets
US FDA RESTRICTEDus_fda_restricted
Record statusInformational public record
Record timelineFirst seen: 2025-01-16T18:32:46Last seen: 2026-07-05T20:44:02
Risk Topicsdebarment

Compliance Context Review

Independent assessment

SIC Group prepares source-backed risk context, exposure memos, and remediation pathways for individuals seeking to clarify a public record or counterparty signal.

Source-list verification
Banking and counterparty exposure memo
Regulatory status and remediation triage
Request Risk Assessment
Confidential Review
Report an error or request a correction
Export PDFSubscriber Only